Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.61M Buy
20,300
+1,100
+6% +$129K 1.4% 20
2026
Q1
$2.31M Hold
19,200
1.37% 19
2025
Q4
$2.02M Buy
19,200
+47
+0.2% +$4.41K 1.25% 20
2025
Q3
$1.61M Hold
19,153
1.01% 27
2025
Q2
$1.52M Buy
19,153
+31
+0.2% +$2.46K 1.02% 26
2025
Q1
$1.72M Sell
19,122
-712
-4% -$66.5K 1.14% 21
2024
Q4
$1.97M Buy
19,834
+111
+0.6% +$11.4K 1.32% 20
2024
Q3
$2.24M Sell
19,723
-2
-0% -$238 1.6% 15
2024
Q2
$2.44M Sell
19,725
-1,017
-5% -$131K 1.88% 12
2024
Q1
$2.74M Buy
20,742
+916
+5% +$113K 2.01% 12
2023
Q4
$2.16M Sell
19,826
-151
-0.8% -$15.7K 1.91% 13
2023
Q3
$2.06M Sell
19,977
-10
-0.1% -$1.08K 1.96% 13
2023
Q2
$2.31M Sell
19,987
-40
-0.2% -$4.54K 2.12% 11
2023
Q1
$2.13M Sell
20,027
-268
-1% -$28.9K 2% 12
2022
Q4
$2.25M Sell
20,295
-40
-0.2% -$4.09K 2.14% 11
2022
Q3
$1.75M Buy
20,335
+300
+1% +$26.8K 1.89% 13
2022
Q2
$1.83M Buy
20,035
+515
+3% +$45.7K 1.87% 14
2022
Q1
$1.6M Hold
19,520
1.46% 20
2021
Q4
$1.5M Buy
+19,520
New +$1.55M 1.34% 21
2019
Q4
$1.73M Buy
+19,885
New +$1.63M 1.7% 12

Other funds holding MRK

TI-Trust's MRK Position: Q2 2026 in Review

TI-Trust increased its Merck (MRK) stake by 5.7% in Q2 2026, buying an estimated $129K and bringing the position to 20,300 shares worth $2.61M. The position accounts for 1.4% of the portfolio, ranked #20.

TI-Trust first reported a position in MRK in Q4 2019 and has held it in 20 quarters since. The position peaked at $2.74M in Q1 2024. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • TI-Trust held 20,300 shares of Merck worth $2.61M as of Q2 2026.
  • TI-Trust bought 1,100 Merck shares in Q2 2026, an estimated $129K.
  • Merck made up 1.4% of TI-Trust's portfolio in Q2 2026, its #20 holding.
  • TI-Trust first reported a position in Merck in Q4 2019 and has held it in 20 quarters since.
  • TI-Trust's Merck position peaked at $2.74M in Q1 2024.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on TI-Trust's 13F filing for Q2 2026, filed 23 Jul 2026.